Mos-related activators include a variety of chemicals that indirectly influence the activity of the Mos protein or the pathways associated with it. Mos, known for its role in oocyte maturation and embryonic development, primarily influences the MAPK/ERK signaling pathway, which is crucial for cell cycle regulation and differentiation. The listed chemicals, such as U0126, PD98059, and SP600125, are inhibitors of key enzymes in these pathways and can be used to study the indirect effects on Mos activity. While these chemicals primarily function as inhibitors, their role in research is to modulate the signaling cascades that Mos is a part of, thereby providing insight into its biological functions. Compounds targeting MEK, PI3K, and mTOR pathways are particularly relevant, as these pathways intersect with the signaling routes regulated by Mos. By manipulating these pathways, researchers can better understand the role of Mos in cellular processes and its implications in diseases, especially in contexts where Mos function might be aberrant.
It's important to note that the effects of these compounds on Mos and its associated pathways are complex and context-dependent. Their use in research settings helps in dissecting the intricate mechanisms of cell cycle regulation and development. However, the exact mechanisms by which they influence Mos activity require detailed and specific investigation in relevant biological models. The study of Mos and its modulation by these chemicals remains a dynamic field with potential implications in developmental biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, which can indirectly modulate Mos signaling through the MAPK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may interact with pathways influenced by Mos. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially affecting pathways related to Mos. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which could indirectly affect signaling pathways associated with Mos. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially impacting Mos-related signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that might influence pathways relevant to Mos activity. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Another kinase inhibitor, might modulate signaling pathways related to Mos. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A tyrosine kinase inhibitor, could have implications for Mos signaling pathways. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR inhibitor, may indirectly influence pathways involving Mos. | ||||||